PEMBROKE1
7日前
I own this stock and I wish it would do well.
I wish I was upbeat like you
I would love this stock to get into the cents
I have owned this stock for a few years now. (I would love to see it make a run on real good news).
But it is what it is for now.
They have recently added to their board of Directors to comply with the OTC rules.
Very little trading. (approx. a few thousand to maybe 4,000,000 daily).
Over 3,000,000,000 shares outstanding.
It doesn't matter what you think the YEILD sign is bad news.
eBay seller
Buying some shares back but issued 25,000,000 in the last three months.
They have added to the outstanding shares
You can go to their website and look under Stock Data. (OTC MARKETS)
https://www.mbakcorp.com/company.asp?contenu=company
Dnx_PH
1週前
A Concession to Price Action
It is fascinating to watch the classic playbook unfold whenever an OTC chart gets coiled and ready to move. When short-sellers or “critics” realize they can no longer suppress the actual accumulation or break the technical setup, they inevitably pivot to a self-proclaimed "honest watchdog" routine. They try to act like high-and-mighty judges who just "won" a debate because someone refused to get dragged into the mud over irrelevant administrative semantics.
The absolute reality is that real traders focus on price action, core financial data, and chart setups—not playing amateur internet detective over a temporary website link or corporate registry syntax. While the noise machine hyper-focuses on cosmetic distractions, the actual underlying fundamentals tell the real story:
1. The Share Structure & Buyback: The tight share structure remains locked down, and the company's active share repurchase program is the ultimate indicator of management's corporate confidence—literally using capital to retire shares at these suppressed levels.
2. World-Class Leadership: High-quality board members and elite international engineers have been brought in to steer the physical expansion.
3. Solid Financial Infrastructure: Revenue foundations remain concrete, backed by millions in recent order fulfillments and massive international pipeline deals.
4. Frivolous Legal Noise: The sudden influx of legal filings reads like a textbook form of corporate intimidation—a standard extortion play designed to shake retail, generate artificial panic, and force cheap accumulation. These types of tactics historically get tossed out the moment they hit a judge's desk.
If anyone chooses to dump their position over a broken hyperlink, that's their choice—manufactured panic always separates the weak hands from the asset. But the classic rule of thumb for micro-caps never alters: the best entries present themselves right when the board is flooded with orchestrated chaos and the price is dragging bottom.
When people spend their entire day digging through records—without the board ever truly knowing who they are working for, what their actual purpose is, or who is funding the effort—their true intentions become blindingly obvious. There is zero requirement for the board to reach a consensus on administrative semantics. Ultimately, the tape itself will settle this debate, and the market will show exactly where the value lies when the short squeeze triggers and the price breaks out toward three cents. Let the "honest watchdogs” keep writing essays; the market will handle the rest.
Dnx_PH
1週前
Imagine Sitting Here Watching a Stock Chart While Staring at a Website Menu
It's hilarious watching people write essays about website navigation paths and corporate registry filing semantics while the market is completely ignoring the noise.
If you want a "perfect" blue-chip corporate presentation with a pristine IT staff and flawless PR, go buy Micron at an entirely different valuation. This is the OTC. You trade the chart, the accumulation, and the impending short squeeze, not whether a localized regional partner in a developing country has a world-class IT department checking their hyperlinks every afternoon.
The data that actually matters—the financials, the ultra-tight share structure, and the coiled spring on the daily chart—tells the real story. If people want to dump their shares because they're terrified of a broken menu button, let them. The volume is building, the squeeze is primed, and the path to three cents is loading regardless of message board essays. See you at the tape.
Dnx_PH
1週前
Total pre-market FUD. Classic FUD right before the opening bell.
If you actually go directly to the main corporate domain, the website is completely fine and fully functional:
https://letsatsipower.com/
The issue being pointed out is just a broken, unmonitored internal subdirectory link (/news-update/) that likely got hit by a malicious script bot or an old redirect loop. It happens all the time to corporate archives. Even some of their social links like X or Facebook are still being set up or worked on, which is totally normal for a site currently under construction and being built out. Instead of panicking on a message board, someone just needs to report the broken links to their IT team so they can patch it up.
The main site is solid and it looks like a great start since they made the official announcement. While we don't know the exact day ground broke, a massive international project like this is very likely actively being built out right now.
Bottom line: That is the absolute golden rule of OTC investing. You buy when there is blood or confusion in the streets and the price is low, not when everything is polished, perfect, and already priced in at the top. Don't let someone trick you with a dead link when the root site is completely fine.
OTC_Watchdog
1週前
On March 25, 2026, MBAK issued a press release naming LETSATSI Power South Africa as its exclusive partner for a $57.5M Zambian Copperbelt BESS project.
Today, their website tells a different story: https://letsatsipower.com/news-update/
Click "News Updates." Click "Our Team." Click "Contact Us."
All three redirect to DEPOBOS88 — an Indonesian online slot machine platform. Lucky Spin. Minimum deposit Rp 10,000. 18+ only.
A real energy company actively executing a $57.5 million project with international lenders and a 20-year PPA would notice their website redirecting to an Indonesian gambling platform within hours.
This website has been broken and unmonitored for weeks.
Does this look like a company that has ordered, paid, and is currently waiting to receive a delivery of products from MBAK out of China for a $57.5M project?
Fattydaddy29
3週前
Well, I’m the guy with the gut feeling, and I don’t knock anybody who stays in it. I’ve even said hey if this thing pops and I made a mistake then oh well. But it got me looking into other companies that are in this same industry, battery storage. And I found what appears to be a good company who reports real contracts that are completely verified. They’ve been around for 18 years and based right here In the USA. In fact, they’re starting up another plant in Pittsburgh Pennsylvania. Granted it’s not a pink sheet penny stock and I’m not buying 1 million shares, but I feel it’s real value And a solid company. This is just a real me talking no AI Assisted paragraphs.
Dnx_PH
3週前
Building Value: The Reality of MBAK’s Momentum
It is a testament to the company’s progress that the opposition has nothing left but to rehash the same stale, repetitive complaints. Whether appearing on the public board or arriving directly in my inbox, these messages serve only to highlight the lack of substance behind the bearish stance. It is clear that some prefer to dwell on subjective "gut feelings" rather than confront the objective reality of the business. By ignoring the fundamental data, these individuals blind themselves to the very momentum they claim does not exist.
While they are busy cycling through emotional venting, the actual story of the company remains consistent and rooted in tangible action:
• Operational Momentum: The company continues the systematic execution of its $65 million order backlog. This fulfillment process is the primary driver of growth, providing the operational backbone that detractors conveniently choose to ignore.
• Financial Momentum: Strong revenue growth continued into Q1 2026, with the company reporting revenue and net income figures that reflect solid gross margins.
• Strategic Foundation: The company has actively expanded its capabilities, such as incorporating MBAK India Private Ltd., specifically designed to navigate regulatory frameworks and streamline the integration of its Battery Energy Storage Systems (BESS).
• Share Structure Discipline: The company maintains a stable share count, avoiding toxic dilution. The recent issuance of approximately 25 million shares appears strategically aimed at aligning high-caliber talent with the board and organization.
• Share Repurchase Program: Demonstrating confidence in its valuation, the Board of Directors has authorized a $500,000 share repurchase plan, funded directly from cash reserves and recent order fulfillment payments.
• Facility Expansion: Plans are underway to expand operations into a 40,000 sq. ft. U.S. manufacturing facility in Wilmington, NC, by September 2026.
• Recurring Revenue Floor: Recent earnings guidance highlighted a new specialized cell order delivering approximately $750,000 per month for one year, providing a consistent revenue stream expected to cover corporate overhead.
• Global Expansion: Documented growth in regions like Africa, India, and Europe serves as a concrete indicator of the firm's expanding international footprint, far removed from the speculative, subjective "gut feelings" pushed by those who have already exited their positions.
Market Trajectory and Outlook
The disconnect between the recycled hit pieces of the “critics” and the company’s actual trajectory is wider than ever. While others speculate on past price points or vent personal frustrations, my focus here remains on the execution of the $65 million backlog and the compounding value created by these operational milestones. As the company continues to hit its targets and expand its footprint, the underlying fundamentals are becoming increasingly difficult for the "usual suspects" to dismiss.
I am uninterested in the static of those who would rather complain than observe the construction of value. I am positioned to remain focused on the upside, tracking the company's progress as it translates this operational momentum into long-term growth. The math and the milestones speak for themselves; I am ignoring the noise and staying focused on the value being built.
OTC_Watchdog
3週前
The address Michelle Boos gave the federal court for MBAK does not exist.
In her own filing to the United States District Court, Michelle Boos listed the following address for herself and MBAK:
4120 US HWY 421 N, Building 4, Wilmington, NC 28401
On June 15, 2026, the court docketed two returned envelopes — Documents 47 and 48 — stamped by USPS: "RETURN TO SENDER — NO SUCH NUMBER — UNABLE TO FORWARD."
USPS confirmed the address does not exist.
This address is also different from every other address MBAK has filed in official documents:
— OTC Markets profile: 3940 US Highway 421 N, Wilmington, NC 28401
— Wyoming SOS 2026 Annual Report, certified by Boos under penalty of perjury: Wilmington Trade Center, Building 3, 3940 US Highway 421 N
Three filings. Three different addresses. Two different street numbers. Two different building numbers.
Two questions follow from this:
First: the address Boos gave the court is different from every other address she has filed elsewhere — and it does not exist. Did she provide a non-existent address to the federal court to avoid being contactable, and with that delay the legal proceedings against her?
Second: if the address she gave the court is wrong, are the addresses she certified to Wyoming SOS and OTC Markets also wrong? At this point, does MBAK have any verified, deliverable address at all?
A company and its management that cannot provide a consistent, accurate address across government filings, regulatory disclosures, and federal court submissions raises a straightforward question: what exactly are they hiding, and from whom?
Case record is public: PACER, Case No. 4:26-cv-00091-JDR-SH, N.D. Oklahoma.
OTC_Watchdog
3週前
Update — Case No. 4:26-cv-00091-JDR-SH, N.D. Oklahoma — June 15, 2026
Judge John D. Russell issued a Minute Order today granting Plaintiffs' motion to strike.
The Court ruled that Michelle Boos and Nolin Han — as unrepresented, pro se parties — cannot file requests for relief on behalf of corporate entities. The filings submitted by Boos and Han on behalf of MIA Global USA, Inc. and MBAK Energy Solutions, Inc. have been stricken from the record.
The Court's order states directly: "Defendants MIA Global USA, Inc. and MBAK Energy Solutions, Inc. must seek relief through counsel."
The corporate defendants now have no filings on the record, no legal representation, and passed response deadlines. Their only attempt to respond has been struck by the Court.
The judge has now told MBAK directly: get a lawyer.
Why won't they?
The door for a default motion is now wide open.
Drallision
3週前
You’re correct, plus the Q was never filed with OTC Markets, which makes them 30 days in default. Boos spoke about what she posted on her website. Fraud, hoax, lies. This is criminal, but then again, Boos is a lifelong SCAM ARTIST!
Dnx_PH
3週前
It’s almost impressive how the script never changes. We are watching an "expert-level" display of redundancy—the same claims, the same "concerns," and the same predictable attempts to generate fear, all while ignoring the actual progress happening on the ground. It is honestly exhausting that these critics continue to recycle these loaded questions, especially when management already provided a transparent, refreshing, and comprehensive breakdown during the recent earnings call—a level of clarity that is practically unheard of in the murky, bottom-feeding world of OTC micro-caps.
While the "detectives" are busy playing games in the comments, the company continues to execute. Let’s refocus on the verifiable data, not the theatrics.
The Financial and Operational Reality:
• Proven Revenue: The company reported $3.01 million in revenue and $1.40 million in net income for Q1 2026, maintaining solid gross margins of approximately 51%.
• Operational Integration: To address concerns regarding certification, the company incorporated a local subsidiary, MBAK India Private Ltd., specifically designed to navigate India's regulatory environment and streamline BESS integration for its $65 million order backlog.
• Strategic Growth: These efforts are bolstered by new partnerships in Zambia’s Copperbelt, proving that the company is actively expanding its footprint where it counts.
Market Outlook:
The broader market move I anticipated is now unfolding, providing the necessary tailwind for MBAK. This macro shift significantly increases the probability of achieving my established price targets as the market begins to align with the company’s underlying fundamentals. In my opinion, a quick move to 3 cents is even more possible, followed by a sustainable appreciation into the 8 to 10-cent range as the company’s real-world progress compounds. The math is certified, the execution is tangible, and the upside remains my primary focus. Let the critics continue to repeat their tired conspiracy theories.
OTC_Watchdog
3週前
A simple question for MBAK management.
MBAK has announced the following delivery commitments, all of which are past due or nearly so:
— October 27, 2025: Delivery of 100 MWh of BESS units to an Indian power grid customer by April 30, 2026 — now 46 days overdue
— March 18, 2026: Shipments to India and Zambia announced as already underway — 89 days ago
— April 29, 2026: "Confirmed on-time shipment" of eleven BESS units to India and Africa — 47 days ago, also exceeding the maximum 45-day door-to-door transit time
— April 29, 2026: "Beginning of delivery" of ESS systems to Kenyan coffee farmers — 47 days ago, no follow-up
— April 29, 2026: Additional 40 MWh to India to be delivered by June 2026 — 15 days remaining, no progress update
Standard sea freight from China to India or Zambia takes a maximum of 45 days door-to-door. The March 18 shipments — announced 89 days ago — should have arrived by early May at the latest. The April 29 shipments — 47 days ago — should have arrived by mid-June at the latest. Neither has been confirmed.
On the same day as the April 29 announcement, MBAK also claimed "confirmed on-time shipment" of eleven BESS units to India and Africa. Nineteen days later, on the May 18 earnings call, Chairman Boos stated that containers were still in China awaiting Indian customs paperwork and customer payment. Dr. Konda confirmed that Indian government certification required for delivery did not yet exist.
MBAK's own management contradicted their own press release on their own earnings call.
It is now June 15. No press release has confirmed that a single shipment has arrived at its destination. The OTC Markets news page has been silent since March 18 — the same day shipments were declared underway.
Has a single customer taken physical delivery of BESS units? Has a single customer payment been received?
The silence answers the question.
Dnx_PH
4週前
Ignoring the Noise: Why MBAK’s Business Execution is the Real Story
It’s honestly exhausting and quite sad to witness. It’s hard not to imagine someone hunched over a keyboard for hours on end, obsessively typing away and digging through legal dockets for who knows who and for what reason—a pursuit that seems to offer no real reward. Anyone who has spent any real time watching the markets knows that these kinds of lawsuits are incredibly common, and more often than not, they end up being dismissed, settled for pennies, or dragged out until they lose all relevance. Getting bogged down in the minute details of "service status" or "default judgments" as if they are some kind of death knell for a company is just noise—it’s legal theatrics, not business analysis.
This noise is often amplified by a single, persistent voice attempting to cast doubt by obsessively framing procedural hurdles as catastrophic events, or by pushing groundless speculation about the "Expert Market" to incite fear. We’ve even seen some recent back-and-forth on the board where this same narrative attempted to over-analyze the contractual relationships involved in the case, only to overlook the actual scope and nature of the claims being made. In my experience, these distractions are designed to obscure the bigger picture. When you look at the company’s certified financial report and the concrete evidence presented during the recent earnings calls, the trajectory for success becomes clear. The company is actively executing on its business plan, and these operational milestones—not the theatrics of online critics—provide the true indicator of the future.
While some are busy playing amateur detective, the company is actually out there executing on real work. That’s where the value is created, not in the courtroom.
Let’s look at the actual facts:
• Share Structure Discipline: The company continues to maintain a stable share count with no toxic dilution. The recent ~25 million share issuance appears aimed at aligning high-caliber talent with the board and organization.
• Financial Momentum: Strong revenue growth continued into Q1 2026 with $3.01 million reported and $1.40 million in net income, reflecting solid gross margins around 51%.
• Operational Progress: The company has produced and positioned BESS units for delivery to India and Africa (with over 55 MWh of capacity referenced in updates). They continue to target substantial additional capacity (including the expanded India contract) through 2026, with the new MBAK India subsidiary supporting fulfillment of the overall $65 million backlog alongside Zambia partnerships.
• Global Expansion: MBAK has incorporated a new subsidiary, MBAK India Private Ltd., to streamline BESS integration for its $65 million order fulfillment, while also securing new partnerships for renewable power projects in Zambia’s Copperbelt.
• Share Repurchase Program: In a move demonstrating confidence in the company's valuation, the Board of Directors has authorized a $500,000 share repurchase plan under SEC Rule 10b-18, funded directly from cash reserves and recent order fulfillment payments.
• Facility Expansion: Plans are in place to move into a 40,000 sq. ft. U.S. manufacturing facility in Wilmington, NC by September 2026.
• Recurring Revenue Floor: Earnings call highlighted a new specialized cell order delivering approximately $750,000 per month for one year, expected to help cover corporate overhead.
Market Outlook:
Beyond the immediate noise, I am looking at the broader picture. The overall market is setting up for a significant run based on the technical charts. This shift is likely to catch many off guard, especially as the current environment starts to feel bleak and discouraging to the average observer. However, this is precisely the type of sentiment that historically signals a prime buying opportunity for those who can see past the temporary gloom.
I’m more interested in the actual business operations and the long-term growth trajectory than I am in following every repetitive update on a lawsuit that is likely to go nowhere. Genuine progress is what moves the needle, and that is exactly what the company is delivering. With experienced leadership and clear delivery milestones, the upside potential is significant. My focus remains on my established price targets, because that is where the fundamental value of the company’s real-world progress will eventually be reflected.
OTC_Watchdog
4週前
@Karmine — you've done more research than most people on this board and you're asking the right questions. But I'd push back on one underlying assumption running through your post: that the $65M order book, the India deliveries, and the tariff explanation are real because MBAK said so.
What is the actual evidence that the $65M order book exists? A press release. What is the evidence that deliveries happened? Another press release. On the May 18 earnings call Boos confirmed the Indian customer had not paid and the certification lab required for delivery did not exist.
Meanwhile MBAK's own certified financial filings show a company that reported $3,010,062 in revenue in Q1 2026 and received zero dollars from customers in the same period. That's not an outside critic's interpretation — it's the arithmetic of their own cash flow statement, certified under penalty of law.
On the reverse split and stock loan — neither was ever a realistic option at this share price and market cap. Their absence proves nothing.
The gap here is not between optimists and pessimists. It's between what Boos says publicly and what Boos certifies in writing. At what point do those contradictions become too big to ignore?
Karmine
4週前
Definitely some unanswered questions here. I find it commendable that Boos did not try an RS or some type of equity loan or draw after the shell was purchased. The staff, the investment, the procurement, and all the OTC red tape and PR has been funded though revenue or out of BOD and or Boos pockets. In addition, if the high tariff structure on Chinese goods sold to India was not fully anticipated, it could have left MBAK cash strapped. $65 million order could lead to north of $10M in tariffs alone. Tough to generate money to the bottom line when 8 figures gets skimmed off the top. I would assume that this may be why there are challenges when it comes to asset allocation. I have some acquaintances that do trade in India and they are know for being slow payers. Hence why Arnold only inventories and sells one rug at a time. If this $65M deal has terms linked to it, it could mean that there is payment lag. Something that even Guido and Nunzio couldn't help with. The obvious conclusion is that cash demands exceed current supply (which happens all the time with rapidly growing businesses) or it's been difficult to find the right attorney to client relationship (remember they are in Asia, not OKC). Lets hope the judge is very compassionate and understanding and gives them more time to mount their own offensive. I have lots of shares here and I am rooting for the home team.
OTC_Watchdog
4週前
@Karmine — fair reading, and you're right that the Master Agreement is between the plaintiffs and MIA Global, not MBAK directly.
The connection to MBAK runs through the RICO claim, not the contract. Under civil RICO, all members of an alleged enterprise are jointly liable — the contract establishes the underlying fraud, and the enterprise allegations in the Amended Complaint name MIA Global, MIA USA, and MBAK as the corporate vehicles through which the scheme operated. Paragraph 109 states the three corporate entities "have no meaningful separation from the individual defendants." That's the alter ego theory — the corporate boundaries don't shield MBAK if the court finds they were operated as a single enterprise.
On "told" not being a contract — correct, which is why the securities fraud counts exist alongside the contract claim. The ALYI shares offered to Long and Anton as inducement are the basis for Counts 7 and 8 (Federal Securities Fraud and State Law Securities Fraud), independent of any written agreement.
On the strength of the case — consider this: if the plaintiffs' case is as weak as it appears to you, the defendants have every incentive to retain counsel and win quickly. A weak case is easy to defeat with competent representation. Instead the corporate defendants are heading toward automatic default, which carries the same legal consequences as losing at trial. A defendant who believes they are in the right and has the means to prove it does not allow that to happen.
The question of why they are not defending themselves is more important than the question of whether the case is strong or weak.
OTC_Watchdog
4週前
@Karmine — the contractual relationship is documented in the court record. Here are the key public filings:
1. The Master Distribution Agreement — the contract between the plaintiff and MIA Global Inc., signed by Michelle Boos as Founder and Chairman. Dated February 10, 2025.
https://archive.org/details/mia-global-master-distribution-agreement-jimmy-long-michelle-boos-2025
2. The Amended Complaint — explains how MBAK connects to MIA Global and the plaintiffs. Paragraph 55 states Boos told the plaintiffs she was acquiring ALYI and converting it to the symbol MBAK. The corporate veil and enterprise allegations name MIA Global, MIA USA, and MBAK together explicitly.
https://archive.org/details/michelle-boos-gabriel-carrelo-mbak-mia-global-federal-amended-complaint-26-cv-00091-sh
3. Plaintiffs' Response to Carrelo's Motion to Dismiss — introduces Gabriel Carrelo, Boos's son, as the "financial architect, or in layman's terms, the Bagman" of the enterprise. Includes a photo from May 2, 2025 showing Carrelo, Boos, and the plaintiffs at a meeting to discuss a fleet of golf carts that, per the filing, would never materialize.
https://archive.org/details/michelle-boos-mbak-mia-global-rico-lawsuit-response-to-dismissal
All three are public court documents from Case No. 4:26-cv-00091-SH, N.D. Oklahoma.
Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Homebrew
1日前
メールアドレスで登録
